- Home
- BMY vs CME Comparison
BMY vs CME Comparison
Compare BMY & CME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- CME
- Stock Information
- Founded
- BMY 1887
- CME 1898
- Country
- BMY United States
- CME United States
- Employees
- BMY N/A
- CME N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- CME Investment Bankers/Brokers/Service
- Sector
- BMY Health Care
- CME Finance
- Exchange
- BMY Nasdaq
- CME Nasdaq
- Market Cap
- BMY 120.5B
- CME 100.2B
- IPO Year
- BMY N/A
- CME 2002
- Fundamental
- Price
- BMY $46.98
- CME $285.98
- Analyst Decision
- BMY Hold
- CME Hold
- Analyst Count
- BMY 16
- CME 16
- Target Price
- BMY $58.93
- CME $256.56
- AVG Volume (30 Days)
- BMY 15.5M
- CME 2.0M
- Earning Date
- BMY 04-24-2025
- CME 07-23-2025
- Dividend Yield
- BMY 5.29%
- CME 3.71%
- EPS Growth
- BMY N/A
- CME 13.21
- EPS
- BMY 2.67
- CME 9.94
- Revenue
- BMY $47,636,000,000.00
- CME $6,274,100,000.00
- Revenue This Year
- BMY N/A
- CME $9.32
- Revenue Next Year
- BMY N/A
- CME $4.04
- P/E Ratio
- BMY $17.55
- CME $28.77
- Revenue Growth
- BMY 4.62
- CME 11.73
- 52 Week Low
- BMY $39.35
- CME $190.70
- 52 Week High
- BMY $63.33
- CME $287.05
- Technical
- Relative Strength Index (RSI)
- BMY 42.78
- CME 65.38
- Support Level
- BMY $46.47
- CME $275.82
- Resistance Level
- BMY $47.36
- CME $285.87
- Average True Range (ATR)
- BMY 1.20
- CME 4.67
- MACD
- BMY 0.32
- CME 0.45
- Stochastic Oscillator
- BMY 67.42
- CME 95.01
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About CME CME Group Inc.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.